Real-World Experience with Cangrelor as Adjuvant to Percutaneous Coronary Intervention: A Single-Centre Observational Study

BACKGROUND: Reversible P2Y12 inhibition can be obtained with cangrelor administered intravenously. More experience with cangrelor use in acute PCI with unknown bleeding risk is needed. OBJECTIVES: To describe real-world use of cangrelor including patient and procedure characteristics and patient out...

Descripción completa

Detalles Bibliográficos
Autores principales: Thim, Troels, Jakobsen, Lars, Jensen, Rebekka Vibjerg, Støttrup, Nicolaj, Eftekhari, Ashkan, Grove, Erik Lerkevang, Larsen, Sanne Bøjet, Sørensen, Jacob Thorsted, Carstensen, Steen, Amiri, Sahar, Veien, Karsten Tange, Christiansen, Evald Høj, Terkelsen, Christian Juhl, Maeng, Michael, Kristensen, Steen Dalby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289876/
https://www.ncbi.nlm.nih.gov/pubmed/37361000
http://dx.doi.org/10.1155/2023/3197512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289876/
https://www.ncbi.nlm.nih.gov/pubmed/37361000
http://dx.doi.org/10.1155/2023/3197512

Ejemplares similares